KLF15 activates PGC1α to rewire mitochondrial homeostasis and overcome cisplatin resistance in lung adenocarcinoma
Wan Lin, Lijuan Li, Yuwen Bai, Mai Wen, Wenjie Dong, Ruikun Ji, Jianqun Ma, Xiaodong Ling · 2026
Read KLF15 activates PGC1α to rewire mitochondrial homeostasis and overcome cisplatin resistance in lung adenocarcinoma by Wan Lin, Lijuan Li, Yuwen Bai, Mai Wen, Wenjie Dong, Ruikun Ji, Jianqun Ma, Xiaodong Ling (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13572412.txt.
Description
Wan Lin, with seven colleagues, ran a 2026 study of why lung adenocarcinoma stops responding to the drug cisplatin. This lung cancer type kills more people than any other cancer. The work centres on a gene switch called KLF15 and on the cell powerhouses, the mitochondria, that it helps build.
Resistant cancer cells held low KLF15, fewer powerhouses, and lower levels of harmful oxygen byproducts. Restoring KLF15 made cells in dishes and tumours in mice respond to the drug again. KLF15 switched on a partner gene, PGC1α, which drives powerhouse growth. Removing that partner undid the gain and brought resistance back. Cell groups with few powerhouses or low KLF15 were resistant from the start. The pair marks a fresh target for beating drug failure.
Catalog record
| CREATOR | Wan Lin, Lijuan Li, Yuwen Bai, Mai Wen, Wenjie Dong, Ruikun Ji, Jianqun Ma, Xiaodong Ling |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50948 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |